In Brief: Wyeth-Lederle RotaShield
Executive Summary
Wyeth-Lederle RotaShield: Centers for Disease Control & Prevention Advisory Committee on Immunization Practices votes Feb. 11 to recommend routine use of rotavirus vaccine in infants at 2, 4 and 6 months. Wyeth's tetravalent oral rotavirus vaccine application is pending at FDA; the agency's Vaccines Advisory Committee reviewed the product favorably on Dec. 12 ("The Pink Sheet" Dec. 22, 1997, p. 13)...